Transgenomic, Inc. (TBIO) Unlocking the Power of Non-Invasive Liquid Biopsies with ICE-COLD PCR™ Technology
Transgenomic, Inc. (NASDAQ: TBIO) is a global biotechnology company advancing personalized medicine in cardiology, oncology and inherited diseases through progressive diagnostic technologies, such as its revolutionary ICE-COLD PCR™ (MX-ICP). Through this technology, the company provides more sensitive and accurate mutation detection without major costs or impact to current processes. In May, Transgenomic built on the versatility of its MX-ICP platform through the launch of a novel epidermal growth factor receptor (EGFR) CLIA test for mutation detection in cancer patients, effectively opening the door for more informed diagnoses, better treatment decisions and ongoing patient monitoring moving forward. The first tests using…